The Indian Pharma Industry under the Product Patent Regime

            
 
Strategic Management|Management Strategy |Business Strategy Case Study|Business Strategy|Case Study|Case Studies

ICMR HOME | Case Studies Collection

Case Details:

Case Code : BSTR169
Case Length : 26 Pages
Period : 1990-2005
Organization : -
Pub Date : 2005
Teaching Note :Not Available
Countries : India
Industry : Pharmaceutical

To download The Indian Pharma Industry under the Product Patent Regime case study (Case Code: BSTR169) click on the button below, and select the case from the list of available cases:

Business Ethics Case Studies | Case Study in Management, Operations, Strategies, Business Ethics, Case Studies

OR


Buy With PayPal

Amount to be paid:



Prefer to pay in another currency ?
Select Currency for Payment



Exchange Rates: Click Here
Delivery Details: Click Here

Price:

For delivery in electronic format: Rs. 700;
For delivery through courier (within India): Rs. 700 + Shipping & Handling Charges extra

» Business Strategy Case Studies
» Case Studies Collection
» Business Strategy Short Case Studies
» View Detailed Pricing Info
» How To Order This Case
» Business Case Studies
» Case Studies by Area
» Case Studies by Industry
» Case Studies by Company

Custom Search


Please note:

This case study was compiled from published sources, and is intended to be used as a basis for class discussion. It is not intended to illustrate either effective or ineffective handling of a management situation. Nor is it a primary information source.



Chat with us

Strategic Management Formulation, Implementation, & Control, 12e

Please leave your feedback

Leave Your Feedback

ICMR India ICMR India ICMR India ICMR India RSS Feed

<< Previous

Growth and Nature of the Industry

In 1901, Bengal Chemical & Pharmaceutical Company, the first Indian pharmaceutical manufacturer, was set up in Calcutta5. Over the years the Indian Pharma industry had evolved around the opportunities presented in the regulated environment:

Lack of product patent: The Indian Patent Act 1970, allowed the Indian companies to reverse-engineer patented molecules and launch them in the domestic market.
 
Drugs Price Control Order (DPCO): Price ceiling under DPCO limited the margins and shifted the focus on cost control

Foreign Exchange Regulated Act (FERA): Foreign Exchange Regulated Act led to reduced MNC exposure in India.

Small Scale Industry (SSI): Small-scale industry exemptions led to proliferation of small formulation manufacturers and low cost drug manufacturers.

Business Strategy | Case Study in Management, Operations, Strategies, Business Strategy, Case Studies

In the 1990s, India was looked upon as a source of relatively less expensive pharma products. In 1994, India signed the Trade Related Intellectual Property Rights (TRIPS) agreement.

Indian companies established themselves as suppliers of Active Pharmaceutical Ingredients (APIs) and intermediates for MNCs. Large Indian generics6 companies moved up the value chain to offer custom synthesis and contract manufacturing services for patented molecules7. (Refer Table I for growth of the industry till the late 1990s).

In 2002-2003, retail sales for formulations in India reached Rs 187.9 billion, a 16.6% growth over 2002. Domestic companies had a market share of over 75% in the local market. In the domestic market, anti-infectives formed the largest therapeutic segment in domestic sales...

Excerpts >>


Custom Search





Economics for Managers Textbook
Textbooks Collection

Economics for Managers Workbook
ICMR books Collection

Case Studies in Business Strategy Volume VI

Case Studies in Business Strategy
e-Book on Business Strategy

Case Study Volumes Collection

5] Renamed Kolkata in 2001.

6] Once a drug goes off patent, it becomes an off-patent or generic drug.

7] Outsourcing work done by the Indian companies comes under three categories. The first category is manufacturing outsourcing, which includes the supply of APIs/intermediates; the second category is development outsourcing which deals with conducting pre-clinical and clinical trials; and the third category is customized chemistry services which deals with contract research services for molecules in the pre-launch stage.

 

Case Studies Links:- Case Studies, Short Case Studies, Simplified Case Studies.

Other Case Studies:- Multimedia Case Studies, Cases in Other Languages.

Business Reports Link:- Business Reports.

Books:- Textbooks, Work Books, Case Study Volumes.